Isoflavones Inhibit Hydrogen Peroxide-Induced Angiotensinogen Secretion

Masumi Kamiyama1, Haruna Adachi1, Mau Ogiwara1

  • 1Department of Food and Nutrition, Jumonji University, 2-1-28, Sugasawa, Niiza 352-8510, Saitama, Japan.

Insights

Hydrogen peroxide increases angiotensinogen secretion in kidney cells, potentially worsening diabetic nephropathy. Antioxidants and isoflavones like daidzein and equol can inhibit this process, offering potential therapeutic targets.

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Background:

  • The renin-angiotensin system regulates blood pressure and fluid balance.
  • Dysregulation of this system is linked to kidney disease, including diabetic nephropathy.
  • The specific mechanisms of angiotensinogen's role in diabetic nephropathy are not fully understood.

Purpose of the Study:

  • To investigate the regulation of angiotensinogen expression and secretion in renal proximal tubular epithelial cells.
  • To identify food components that modulate angiotensinogen secretion.
  • To elucidate the cell signaling pathways involved in angiotensinogen regulation.

Main Methods:

  • Primary renal proximal tubular epithelial cells were treated with hydrogen peroxide, antioxidants (catalase), isoflavones (daidzein, equol), and MAP kinase inhibitors (ERK, p38, JNK).
  • Angiotensinogen levels in cell culture medium were measured using ELISA.
  • Angiotensinogen expression was quantified using real-time PCR.
  • MAP kinase pathway involvement was assessed.

Main Results:

  • Hydrogen peroxide stimulation dose-dependently increased angiotensinogen secretion.
  • Catalase, daidzein, and equol significantly reduced angiotensinogen expression and secretion.
  • The MAP kinase pathway, specifically p38 and JNK, was implicated in mediating these effects.

Conclusions:

  • Hydrogen peroxide stimulates angiotensinogen secretion in proximal tubular epithelial cells.
  • Isoflavones (daidzein, equol) and the antioxidant catalase inhibit hydrogen peroxide-induced angiotensinogen secretion.
  • These findings suggest potential dietary interventions for managing diabetic nephropathy by targeting angiotensinogen production.

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
458
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
413
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
8.5K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
548
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
334
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K